APATINIB

Clinical trials for APATINIB explained in plain language.

Never miss a new study

Get alerted when new APATINIB trials appear

Sign up with your email to follow new studies for APATINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New hope for bile duct cancer patients who failed chemo: triple therapy shows promise

Disease control Completed

This study tested a combination of three treatments—drug-coated beads placed directly into the liver tumor, an oral targeted drug (apatinib), and an immunotherapy (PD-1 antibody)—in 20 adults with advanced intrahepatic cholangiocarcinoma (a type of bile duct cancer) that had wors…

Matched conditions: APATINIB

Phase: PHASE2 • Sponsor: Sichuan Cancer Hospital and Research Institute • Aim: Disease control

Last updated Jun 08, 2026 13:13 UTC

APATINIB

Get alerted when new APATINIB trials appear

New hope for bile duct cancer patients who failed chemo: triple therapy shows promise